An NCI-designated Comprehensive Cancer Center
Aijun Liao - Systems Biology

Aijun Liao, M.D., Ph.D.

Visiting Scholar, Department of Systems Biology
Clinical Expertise
  • Cell culture and drug treatment
  • Western blot
  • Real time PCR
  • Flow Cytometry
  • MTT
Research Focus
  • Genetic alterations and CLL biology
Aijun Liao completed her M.D. and Ph.D. from China Medical University, China. As a physician scientist in China, her research focused on the biology of leukemia, lymphoma and multiple myeloma. As a visiting scholar in the Lili Wang Lab, she is currently investigating functional impacts of genetic lesions on B cells and their contributions to CLL.
  • Yang R, Huang J, Ma H, Li S, Gao X, Liu Y, Shen J, Liao A#.Is complement C1q a potential marker for tumor burden and immunodeficiency in multiple myeloma? Leuk Lymphoma. 2019 Jan 10:1-7.
  • Fu D, Li Y, Li J, Shi X, Yang R, Zhong Y, Wang H, Liao A#. The effect of S1P receptor signaling pathway on the survival and drug resistance in multiple myeloma cells. Mol Cell Biochem. 2017 Jan;424(1-2):185-193.
  • Liu H, Wang H, Wu B, Yao K, Liao A, Miao M, Li Y, Yang W. Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma. Clin Exp Pharmacol Physiol. 2017 Oct;44(10):1032-1041.
  • Wang H, Wang X, Liao A, Liu Z. Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway. Mol Cell Biochem. 2017 Sep;433(1-2):141-148.
  • Wang H, Wang X, Xin N, Qi L, Liao A, Yang W, Liu Z, Zhao C. Live kinase B1 maintains CD34+CD38- AML cell proliferation and self-renewal. Mol Cell Biochem. 2017 Oct;434(1-2):25-32.
  • Liao A, Hu R, Zhao Q, Li J, Li Y, Yao K, Zhang R, Wang H, Yang W, Liu Z. Autophagy induced by FTY720 promotes apoptosis in U266 cells. Eur J Pharm Sci. 2012 Apr 11;45(5):600-5.
  • Saadatpour A, Wang RS, Liao A, Liu X, Loughran TP, Albert I, Albert R.Dynamical and structural analysis of a T cell survival network identifies novel candidate therapeutic targets for large granular lymphocyte leukemia. PLoS Comput Biol. 2011 Nov;7(11):e1002267.
  • Liao A, Broeg K, Fox T, Tan SF, Watters R, Shah MV, Zhang LQ, Li Y, Ryland L, Yang J, Aliaga C, Dewey A, Rogers A, Loughran K, Hirsch L, Jarbadan NR, Baab KT, Liao J, Wang HG, Kester M, Desai D, Amin S, Loughran Jr. TP, Liu X. Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia. Blood. 2011 Sep 8;118(10):2793-800.
  • Liu X, Ryland L, Yang J, Liao A, Aliaga C, Watts R, Tan SF, Kaiser J, Shanmugavelandy SS, Rogers A, Loughran K, Petersen B, Yuen J, Meng F, Baab KT, Jarbadan NR, Broeg K, Zhang R, Liao J, Sayers TJ, Kester M, Loughran Jr. TP. Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood. 2010 Nov 18;116(20):4192-201.
In The News